UniProt ID | RL7A_HUMAN | |
---|---|---|
UniProt AC | P62424 | |
Protein Name | 60S ribosomal protein L7a | |
Gene Name | RPL7A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 266 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MPKGKKAKGKKVAPAPAVVKKQEAKKVVNPLFEKRPKNFGIGQDIQPKRDLTRFVKWPRYIRLQRQRAILYKRLKVPPAINQFTQALDRQTATQLLKLAHKYRPETKQEKKQRLLARAEKKAAGKGDVPTKRPPVLRAGVNTVTTLVENKKAQLVVIAHDVDPIELVVFLPALCRKMGVPYCIIKGKARLGRLVHRKTCTTVAFTQVNSEDKGALAKLVEAIRTNYNDRYDEIRRHWGGNVLGPKSVARIAKLEKAKAKELATKLG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Malonylation | GKKAKGKKVAPAPAV CCCCCCCCCCCCCHH | 52.91 | 26320211 | |
11 | Sumoylation | GKKAKGKKVAPAPAV CCCCCCCCCCCCCHH | 52.91 | 28112733 | |
11 | Ubiquitination | GKKAKGKKVAPAPAV CCCCCCCCCCCCCHH | 52.91 | 33845483 | |
20 | Sumoylation | APAPAVVKKQEAKKV CCCCHHCCHHHHHHH | 41.98 | - | |
20 | 2-Hydroxyisobutyrylation | APAPAVVKKQEAKKV CCCCHHCCHHHHHHH | 41.98 | - | |
20 | Acetylation | APAPAVVKKQEAKKV CCCCHHCCHHHHHHH | 41.98 | 25953088 | |
20 | Sumoylation | APAPAVVKKQEAKKV CCCCHHCCHHHHHHH | 41.98 | 28112733 | |
20 | Ubiquitination | APAPAVVKKQEAKKV CCCCHHCCHHHHHHH | 41.98 | 21906983 | |
21 | Sumoylation | PAPAVVKKQEAKKVV CCCHHCCHHHHHHHH | 41.58 | 28112733 | |
21 | Ubiquitination | PAPAVVKKQEAKKVV CCCHHCCHHHHHHHH | 41.58 | 33845483 | |
25 | Ubiquitination | VVKKQEAKKVVNPLF HCCHHHHHHHHCHHH | 45.40 | 22817900 | |
26 | Acetylation | VKKQEAKKVVNPLFE CCHHHHHHHHCHHHH | 59.47 | 26051181 | |
26 | Ubiquitination | VKKQEAKKVVNPLFE CCHHHHHHHHCHHHH | 59.47 | 22817900 | |
26 | Ubiquitination | VKKQEAKKVVNPLFE CCHHHHHHHHCHHHH | 59.47 | 21890473 | |
34 | 2-Hydroxyisobutyrylation | VVNPLFEKRPKNFGI HHCHHHHHCCCCCCC | 67.67 | - | |
34 | Acetylation | VVNPLFEKRPKNFGI HHCHHHHHCCCCCCC | 67.67 | 19608861 | |
34 | Ubiquitination | VVNPLFEKRPKNFGI HHCHHHHHCCCCCCC | 67.67 | 23000965 | |
34 | Ubiquitination | VVNPLFEKRPKNFGI HHCHHHHHCCCCCCC | 67.67 | 21890473 | |
37 | Acetylation | PLFEKRPKNFGIGQD HHHHHCCCCCCCCCC | 69.78 | 26051181 | |
37 | Ubiquitination | PLFEKRPKNFGIGQD HHHHHCCCCCCCCCC | 69.78 | 23000965 | |
37 | Ubiquitination | PLFEKRPKNFGIGQD HHHHHCCCCCCCCCC | 69.78 | 21890473 | |
48 | Sumoylation | IGQDIQPKRDLTRFV CCCCCCCCCCHHHHC | 42.01 | - | |
48 | 2-Hydroxyisobutyrylation | IGQDIQPKRDLTRFV CCCCCCCCCCHHHHC | 42.01 | - | |
48 | Acetylation | IGQDIQPKRDLTRFV CCCCCCCCCCHHHHC | 42.01 | 26051181 | |
48 | Succinylation | IGQDIQPKRDLTRFV CCCCCCCCCCHHHHC | 42.01 | 23954790 | |
48 | Sumoylation | IGQDIQPKRDLTRFV CCCCCCCCCCHHHHC | 42.01 | 28112733 | |
48 | Ubiquitination | IGQDIQPKRDLTRFV CCCCCCCCCCHHHHC | 42.01 | 23000965 | |
48 | Ubiquitination | IGQDIQPKRDLTRFV CCCCCCCCCCHHHHC | 42.01 | 21890473 | |
56 | Ubiquitination | RDLTRFVKWPRYIRL CCHHHHCCHHHHHHH | 49.09 | 21890473 | |
60 | Phosphorylation | RFVKWPRYIRLQRQR HHCCHHHHHHHHHHH | 6.06 | 22817900 | |
71 | Phosphorylation | QRQRAILYKRLKVPP HHHHHHHHHHCCCCH | 6.48 | - | |
72 | Ubiquitination | RQRAILYKRLKVPPA HHHHHHHHHCCCCHH | 48.05 | 23000965 | |
75 | Ubiquitination | AILYKRLKVPPAINQ HHHHHHCCCCHHHHH | 57.64 | 23000965 | |
75 | Ubiquitination | AILYKRLKVPPAINQ HHHHHHCCCCHHHHH | 57.64 | 21890473 | |
84 | Phosphorylation | PPAINQFTQALDRQT CHHHHHHHHHHHHHH | 11.81 | 21955146 | |
89 | Methylation | QFTQALDRQTATQLL HHHHHHHHHHHHHHH | 36.28 | 115492295 | |
97 | Acetylation | QTATQLLKLAHKYRP HHHHHHHHHHHHHCC | 52.82 | 19608861 | |
97 | Malonylation | QTATQLLKLAHKYRP HHHHHHHHHHHHHCC | 52.82 | 26320211 | |
97 | Sumoylation | QTATQLLKLAHKYRP HHHHHHHHHHHHHCC | 52.82 | 28112733 | |
97 | Ubiquitination | QTATQLLKLAHKYRP HHHHHHHHHHHHHCC | 52.82 | 23000965 | |
97 | Ubiquitination | QTATQLLKLAHKYRP HHHHHHHHHHHHHCC | 52.82 | 21890473 | |
101 | 2-Hydroxyisobutyrylation | QLLKLAHKYRPETKQ HHHHHHHHHCCCCHH | 37.03 | - | |
101 | Acetylation | QLLKLAHKYRPETKQ HHHHHHHHHCCCCHH | 37.03 | 25825284 | |
101 | Methylation | QLLKLAHKYRPETKQ HHHHHHHHHCCCCHH | 37.03 | 23748837 | |
101 | Ubiquitination | QLLKLAHKYRPETKQ HHHHHHHHHCCCCHH | 37.03 | 23000965 | |
106 | Phosphorylation | AHKYRPETKQEKKQR HHHHCCCCHHHHHHH | 40.48 | - | |
107 | 2-Hydroxyisobutyrylation | HKYRPETKQEKKQRL HHHCCCCHHHHHHHH | 55.59 | - | |
107 | Ubiquitination | HKYRPETKQEKKQRL HHHCCCCHHHHHHHH | 55.59 | 24816145 | |
120 | Ubiquitination | RLLARAEKKAAGKGD HHHHHHHHHHCCCCC | 46.88 | 22817900 | |
121 | Ubiquitination | LLARAEKKAAGKGDV HHHHHHHHHCCCCCC | 34.67 | 29967540 | |
125 | 2-Hydroxyisobutyrylation | AEKKAAGKGDVPTKR HHHHHCCCCCCCCCC | 47.41 | - | |
125 | Succinylation | AEKKAAGKGDVPTKR HHHHHCCCCCCCCCC | 47.41 | 23954790 | |
125 | Sumoylation | AEKKAAGKGDVPTKR HHHHHCCCCCCCCCC | 47.41 | 28112733 | |
125 | Ubiquitination | AEKKAAGKGDVPTKR HHHHHCCCCCCCCCC | 47.41 | 23000965 | |
131 | 2-Hydroxyisobutyrylation | GKGDVPTKRPPVLRA CCCCCCCCCCCCCCC | 57.76 | - | |
131 | Acetylation | GKGDVPTKRPPVLRA CCCCCCCCCCCCCCC | 57.76 | 25953088 | |
131 | Malonylation | GKGDVPTKRPPVLRA CCCCCCCCCCCCCCC | 57.76 | 26320211 | |
131 | Ubiquitination | GKGDVPTKRPPVLRA CCCCCCCCCCCCCCC | 57.76 | 23000965 | |
131 | Ubiquitination | GKGDVPTKRPPVLRA CCCCCCCCCCCCCCC | 57.76 | 21890473 | |
150 | 2-Hydroxyisobutyrylation | VTTLVENKKAQLVVI EHHHHCCCCEEEEEE | 35.66 | - | |
150 | Acetylation | VTTLVENKKAQLVVI EHHHHCCCCEEEEEE | 35.66 | 25953088 | |
150 | Malonylation | VTTLVENKKAQLVVI EHHHHCCCCEEEEEE | 35.66 | 26320211 | |
150 | Ubiquitination | VTTLVENKKAQLVVI EHHHHCCCCEEEEEE | 35.66 | 21963094 | |
151 | Acetylation | TTLVENKKAQLVVIA HHHHCCCCEEEEEEE | 53.61 | 21466224 | |
151 | Ubiquitination | TTLVENKKAQLVVIA HHHHCCCCEEEEEEE | 53.61 | 22817900 | |
176 | Sumoylation | FLPALCRKMGVPYCI HHHHHHHHHCCCEEE | 38.72 | - | |
176 | 2-Hydroxyisobutyrylation | FLPALCRKMGVPYCI HHHHHHHHHCCCEEE | 38.72 | - | |
176 | Acetylation | FLPALCRKMGVPYCI HHHHHHHHHCCCEEE | 38.72 | 26051181 | |
176 | Malonylation | FLPALCRKMGVPYCI HHHHHHHHHCCCEEE | 38.72 | 26320211 | |
176 | Sumoylation | FLPALCRKMGVPYCI HHHHHHHHHCCCEEE | 38.72 | - | |
176 | Ubiquitination | FLPALCRKMGVPYCI HHHHHHHHHCCCEEE | 38.72 | 23000965 | |
181 | Phosphorylation | CRKMGVPYCIIKGKA HHHHCCCEEEEECCC | 8.22 | 28152594 | |
185 | Acetylation | GVPYCIIKGKARLGR CCCEEEEECCCHHHH | 34.15 | 25953088 | |
185 | Ubiquitination | GVPYCIIKGKARLGR CCCEEEEECCCHHHH | 34.15 | 21963094 | |
187 | Ubiquitination | PYCIIKGKARLGRLV CEEEEECCCHHHHHC | 25.90 | - | |
197 | 2-Hydroxyisobutyrylation | LGRLVHRKTCTTVAF HHHHCCCCCCEEEEE | 32.83 | - | |
197 | Ubiquitination | LGRLVHRKTCTTVAF HHHHCCCCCCEEEEE | 32.83 | 33845483 | |
198 | Phosphorylation | GRLVHRKTCTTVAFT HHHCCCCCCEEEEEE | 18.29 | 21601212 | |
199 | S-palmitoylation | RLVHRKTCTTVAFTQ HHCCCCCCEEEEEEE | 3.17 | 21044946 | |
200 | Phosphorylation | LVHRKTCTTVAFTQV HCCCCCCEEEEEEEC | 29.54 | 23312004 | |
201 | Phosphorylation | VHRKTCTTVAFTQVN CCCCCCEEEEEEECC | 16.39 | 23312004 | |
205 | Phosphorylation | TCTTVAFTQVNSEDK CCEEEEEEECCCCCH | 23.13 | 23312004 | |
209 | Phosphorylation | VAFTQVNSEDKGALA EEEEECCCCCHHHHH | 48.60 | 28985074 | |
212 | 2-Hydroxyisobutyrylation | TQVNSEDKGALAKLV EECCCCCHHHHHHHH | 41.87 | - | |
212 | Acetylation | TQVNSEDKGALAKLV EECCCCCHHHHHHHH | 41.87 | 23954790 | |
212 | Malonylation | TQVNSEDKGALAKLV EECCCCCHHHHHHHH | 41.87 | 26320211 | |
212 | Ubiquitination | TQVNSEDKGALAKLV EECCCCCHHHHHHHH | 41.87 | 23000965 | |
217 | Acetylation | EDKGALAKLVEAIRT CCHHHHHHHHHHHHH | 54.65 | 19608861 | |
217 | Ubiquitination | EDKGALAKLVEAIRT CCHHHHHHHHHHHHH | 54.65 | 23000965 | |
217 | Ubiquitination | EDKGALAKLVEAIRT CCHHHHHHHHHHHHH | 54.65 | 21890473 | |
223 | Methylation | AKLVEAIRTNYNDRY HHHHHHHHHCCHHHH | 24.78 | 115492263 | |
224 | Phosphorylation | KLVEAIRTNYNDRYD HHHHHHHHCCHHHHH | 35.62 | 28152594 | |
226 | Phosphorylation | VEAIRTNYNDRYDEI HHHHHHCCHHHHHHH | 20.16 | 28152594 | |
229 | Methylation | IRTNYNDRYDEIRRH HHHCCHHHHHHHHHH | 36.84 | 115492279 | |
230 | Phosphorylation | RTNYNDRYDEIRRHW HHCCHHHHHHHHHHC | 22.31 | 28152594 | |
234 | Methylation | NDRYDEIRRHWGGNV HHHHHHHHHHCCCCC | 23.51 | 115492287 | |
235 | Methylation | DRYDEIRRHWGGNVL HHHHHHHHHCCCCCC | 35.26 | 115492271 | |
245 | 2-Hydroxyisobutyrylation | GGNVLGPKSVARIAK CCCCCCHHHHHHHHH | 56.62 | - | |
245 | Acetylation | GGNVLGPKSVARIAK CCCCCCHHHHHHHHH | 56.62 | 26210075 | |
245 | Sumoylation | GGNVLGPKSVARIAK CCCCCCHHHHHHHHH | 56.62 | 28112733 | |
245 | Ubiquitination | GGNVLGPKSVARIAK CCCCCCHHHHHHHHH | 56.62 | 23000965 | |
245 | Ubiquitination | GGNVLGPKSVARIAK CCCCCCHHHHHHHHH | 56.62 | 21890473 | |
252 | Sumoylation | KSVARIAKLEKAKAK HHHHHHHHHHHHHHH | 55.60 | - | |
252 | Sumoylation | KSVARIAKLEKAKAK HHHHHHHHHHHHHHH | 55.60 | - | |
252 | Ubiquitination | KSVARIAKLEKAKAK HHHHHHHHHHHHHHH | 55.60 | 27667366 | |
255 | Ubiquitination | ARIAKLEKAKAKELA HHHHHHHHHHHHHHH | 66.67 | 22817900 | |
257 | Ubiquitination | IAKLEKAKAKELATK HHHHHHHHHHHHHHH | 71.68 | 22817900 | |
259 | Ubiquitination | KLEKAKAKELATKLG HHHHHHHHHHHHHHC | 53.18 | 21906983 | |
264 | Sumoylation | KAKELATKLG----- HHHHHHHHHC----- | 45.67 | - | |
264 | Sumoylation | KAKELATKLG----- HHHHHHHHHC----- | 45.67 | - | |
264 | Ubiquitination | KAKELATKLG----- HHHHHHHHHC----- | 45.67 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
106 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL7A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL7A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-34; LYS-97 AND LYS-217, ANDMASS SPECTROMETRY. |